Non-binding Guidance
By Ropes & Gray LLP
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Ropes & Gray LLP
Category: Business News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 21
Description
A Ropes & Gray (RopesTalk) podcast series, focused on current trends in FDA regulatory law, as well as other important developments affecting the life sciences industry.
| Episode | Date |
|---|---|
|
The Administration's Focus on Direct-to-Consumer Prescription Drug Advertising
|
Oct 06, 2025 |
|
Trends in False Advertising and Related Competitor Disputes Involving FDA-Regulated Products
|
May 08, 2025 |
|
Clinical Trial Diversity in Focus
|
Nov 19, 2024 |
|
The Demise of Chevron and Implications for Future APA Challenges
|
Oct 22, 2024 |
|
FDA Regulatory & Enforcement Risks Relevant to Academic Medical Centers, Health Systems and Research Institutions
|
Jun 28, 2024 |
|
U.S. Life Sciences Regulatory and Compliance Outlook 2024 (Part IV): Digital Health
|
Jan 31, 2024 |
|
U.S. Life Sciences Regulatory and Compliance Outlook 2024 (Part I): FDA Enforcement and Litigation
|
Jan 17, 2024 |
|
FDA’s Proposed Rule on Laboratory Developed Tests
|
Oct 30, 2023 |
|
Introducing the U.S. Medical Device Recalls Resource Manual
|
Jul 17, 2023 |
|
Recent Developments in Oncology Drug Development
|
May 10, 2023 |
|
The Regulatory Landscape for Drug Compounding—10 Years After the NECC Outbreak
|
Dec 05, 2022 |
|
Continued Global Pressure on Drug Pricing & Reimbursement and the Next Frontiers for Effective Market Access
|
Oct 13, 2022 |
|
A Recall Readiness Rundown and Recent FDA Actions
|
May 19, 2022 |
|
Recent Developments in FDA Inspection Policy and Implications for Drug and Device Manufacturers
|
Jan 06, 2022 |
|
Rolling Back the Medicare Coverage of Innovative Technology (MCIT) Rule
|
Nov 08, 2021 |
|
COVID-19 Vaccine Mandate Litigation
|
Jul 29, 2021 |
|
The Defense Production Act and the COVID-19 Pandemic
|
May 27, 2021 |
|
European Life Sciences Regulatory Trends with Dr. Lincoln Tsang
|
Apr 28, 2021 |
|
FDA Regulation of COVID-19 Diagnostic Tests and “Return to Work”
|
Jul 21, 2020 |
|
A Discussion of Kisor v. Wilkie
|
Nov 12, 2019 |
|
Examining FDA’s Enforcement Authority Over Stem Cell Clinics and Compounders
|
Jun 28, 2019 |